Evaluation of Balance Using the Biodex Balance System Among Different Subcategories of Low Back Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-55
SponsorCairo University
About this trial
this study aims to evaluate balance using the biodex balance system among patients with spondylosis, spondylolisthesis, and lumber disc prolapse.
Eligibility criteria
Qualifiers
Lumbar spondylosis; defined as degenerative disc disease, osteophyte formation with or without facet joint arthropathy (Natarajan et al., 2021; Christe et al., 2020).
Lumbar spondylolisthesis; defined as anterolisthesis of one vertebral body over another, graded via the Meyerding scale (grade 1 or 2) (Giordan et al., 2023; Chuang et al., 2018).
Lumbar disc prolapse; defined as protrusion, herniation of intervertebral disc (Kang et al., 2016; Hahne et al., 2019).
Age of patients ranges from 35 to 55 years (Albeshri, et.al., 2017)
Disqualifiers
Prior lumbar spine surgery or neurological disorders (e.g., parkinson's, stroke) that may influence balance (soliman et al., 2017).
Fractures of the spine, pelvis or lower extremities, (Karimi et al., 2008).
Leg length discrepancy(Karimi et al., 2008).
Systemic disease such as arthritis, tuberculosis, liver or kidney failure. (Karimi et al., 2008).
Trial design
Treatments tested in this trial
- Assessment of balance will be measured by The Biodex Balance System (BBS) which computes Postural Stability key indices: the medial-lateral stability index (MLSI), anterior-posterior stability index
Treatment groups
80 Participants
are divided into 4 treatment groupsSponsors and collaborators
Cairo University
Lead sponsor
Delta University for Science and Technology
Sponsor institution
Delta University for Science and Technology
Collaborator
Source ClinicalTrials.gov